Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
about
Caenorhabditis elegans as a model for cancer researchThe Impact of the Gut Microbiota on Drug Metabolism and Clinical OutcomeMechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityMicrobial determinants of biochemical individuality and their impact on toxicology and pharmacology.The microbiota, chemical symbiosis, and human disease.In vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells.Microbes, microbiota, and colon cancer.Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.The Microbiome and Musculoskeletal Conditions of Aging: A Review of Evidence for Impact and Potential Therapeutics.Bidirectional interactions between indomethacin and the murine intestinal microbiotaThe microbial pharmacists within us: a metagenomic view of xenobiotic metabolismGlucuronides in the gut: Sugar-driven symbioses between microbe and host.An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.Gut microbiome interactions with drug metabolism, efficacy, and toxicity.Chemical transformation of xenobiotics by the human gut microbiota.Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells.Check your microbiota when taking the drug.Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity.Role of enterohepatic recirculation in drug disposition: cooperation and complications.Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae.Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues.
P2860
Q26828013-76B44EF8-7411-47A8-A324-48BA44F75FECQ28071938-F9F7485A-E35E-48F5-A0D1-7EE4198038D9Q33779249-C16CC9FD-A60F-48BC-A293-A0336E7F3277Q34311685-0B3B6DCF-CC42-4553-95C2-C730FC0E9953Q34493889-AC224074-1758-4247-B425-90B0E91B3390Q34615534-A5623973-5C50-480C-AFBA-722D905FF24DQ34616219-D409211F-CAB7-46CE-AEB5-AA2AA2C5C626Q35035226-5FF124B6-47AD-4186-A0F7-1EF0F4FEB824Q35120938-296DF5C3-FCD1-464F-8922-1029F943B492Q35314338-04A40F99-35A1-4DC5-A4A9-5C01A02C0068Q35742169-AD054E50-4D6F-4A9C-AF4D-F21B3F41D70AQ35871201-12C4F184-A69B-46A7-902F-DB71BCB5C5FDQ35878003-50C93D37-18CA-4AAE-9203-86AFF34FDAD7Q35955534-274FACFA-1909-4786-9E7B-0DE2D844889DQ36340552-714BE843-D421-4AEE-945E-FE7837521415Q38746100-A0D79241-19F6-4845-9A0C-1890D28E3910Q38945423-99A15DD1-9462-4383-9393-65CEE20375A8Q39392651-3644562F-A357-4AB7-BEA7-5A7E7B371739Q41871344-574E3355-3336-4F68-AE76-E649F5474F35Q44876695-541B53AE-973C-433B-A315-4C174944EF0AQ46117153-18F148BC-B867-4BE4-B1B4-545A4E36D43CQ46403916-2B1DBB30-86A5-4EC4-91B9-E98F98508FD4Q46578287-211D879E-18CF-4026-B3DC-72DB44D96BD5Q47263968-0DE7F2AE-CE22-471B-A6D6-1D0BE5F368C0Q48226113-A4AA3390-2EAF-4F26-8DDF-3C37F4B1C62DQ50054146-18B21D12-62B4-4869-94E3-D7D5CE94F24E
P2860
Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bacterial β-glucuronidase inhi ...... of action and pharmacokinetics
@en
Bacterial β-glucuronidase inhi ...... f action and pharmacokinetics.
@nl
type
label
Bacterial β-glucuronidase inhi ...... of action and pharmacokinetics
@en
Bacterial β-glucuronidase inhi ...... f action and pharmacokinetics.
@nl
prefLabel
Bacterial β-glucuronidase inhi ...... of action and pharmacokinetics
@en
Bacterial β-glucuronidase inhi ...... f action and pharmacokinetics.
@nl
P2093
P2860
P1433
P1476
Bacterial β-glucuronidase inhi ...... of action and pharmacokinetics
@en
P2093
Carmen Zhang
Kang Kwang Lee
Kazunori Fujimoto
Kyle S Saitta
Urs A Boelsterli
P2860
P356
10.3109/00498254.2013.811314
P407
P577
2013-07-05T00:00:00Z